Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blue Jet HealthcareBOM:544009 +0.86%64 Gross Margin % is 56.45% as of Mar. 2026, which is 3% above its 10-year median of 55.06. GuruFocus rates BOM:544009 with a GF Score™ of 64/100 and a GF Value™ of ₹562.05 (Fairly Valued). The stock has 10 warning signs investors should review. Among 733 Biotechnology companies, Blue Jet Healthcare ranks worse than 56.34% on this metric.
Blue Jet Healthcare Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.6%.
The historical rank and industry rank for Blue Jet Healthcare's Gross Margin % or its related term are showing as below:
BOM:544009'
s Gross Margin % Range Over the Past 10 Years
Min: 52.22 Med: 55.06 Max: 64.63
Current: 54
During the past 6 years, the highestGross Margin % of Blue Jet Healthcare was 64.63%. The lowest was 52.22%. And the median was 55.06%.
BOM:544009's Gross Margin % is ranked worse than 56.34% of 733
companies
in the Biotechnology industry
Industry Median: 60.91
vs BOM:544009: 54.00
Blue Jet Healthcare had a gross margin of 56.45% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Blue Jet Healthcare was -2.60% per year.
Blue Jet Healthcare (BOM:544009) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Blue Jet Healthcare had a gross margin of 56.45% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Blue Jet Healthcare Gross Margin % Related Terms
Blue Jet Healthcare Gross Margin % Historical Data
* Premium members only.
The historical data trend for Blue Jet Healthcare's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544009 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Blue Jet Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blue Jet Healthcare Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Blue Jet Healthcare's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Blue Jet Healthcare (BOM:544009) has a Gross Margin % of 56.45% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Blue Jet Healthcare and its competitors. This is near median its historical median of 55.06. Over the past decade, Blue Jet Healthcare's Gross Margin % has ranged from 52.22 to 64.63. According to the industry distribution chart, Blue Jet Healthcare ranks #413 out of 733 companies in the Biotechnology industry, placing it in the top 56.3%.
Is Blue Jet Healthcare's Gross Margin % too high?
Blue Jet Healthcare's current Gross Margin % of 56.45% is near median its 10-year median of 55.06. Over the past 10 years, this metric has ranged from a low of 52.22 to a high of 64.63. The Biotechnology industry median Gross Margin % is 60.91. Blue Jet Healthcare's value of 56.45% is 7.3% below this industry median. Based on the distribution chart, Blue Jet Healthcare ranks #413 out of 733 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Blue Jet Healthcare has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Blue Jet Healthcare's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Blue Jet Healthcare ranks #413 out of 733 companies for Gross Margin %. This places Blue Jet Healthcare in the lower half of its industry. The industry median Gross Margin % is 60.91. Blue Jet Healthcare's value of 56.45% is 7.3% below this benchmark. Historically, Blue Jet Healthcare's own Gross Margin % has ranged from 52.22 to 64.63 over the past decade. While the company's 10-year median is 55.06 vs. the industry median of 60.91, Blue Jet Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blue Jet Healthcare's current Gross Margin % of 56.45% is 7.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Blue Jet Healthcare and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blue Jet Healthcare's current Gross Margin % is 56.45%, which is near median its own 10-year median of 55.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blue Jet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Blue Jet Healthcare (BOM:544009) is currently considered Fairly Valued. The stock's GF Value™ is ₹562.05, compared to a current price of ₹589.75 — trading 4.9% above its estimated fair value. The current Gross Margin % is 56.45%, which is near median its 10-year median of 55.06 and 7.3% below the Biotechnology industry median of 60.91. Blue Jet Healthcare's overall GF Score™ is 64/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Blue Jet Healthcare (BOM:544009), the current Gross Margin % is 56.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?
Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued.
The current stock price of ₹589.75 is trading 4.9% above its estimated GF Value™ of ₹562.05.
GuruFocus considers Blue Jet Healthcare to be Fairly Valued.
Key valuation signals for BOM:544009:
Gross Margin %: 56.45% (near median its 10-year median of 55.06)
GF Value™: ₹562.05 vs. price of ₹589.75 (4.9% above fair value)
Industry Position: 7.3% below the Biotechnology median (#413 of 733)
No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
64GF Score
Get the complete analysis for BOM:544009
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544009 has been successfully added to your 
